InterCure Ltd. (TLV:INCR)
Israel · Delayed Price · Currency is ILS · Price in ILA 1,428.00
-74.00 (-4.93%)
Oct 19, 2026, 5:24 PM IDT
InterCure Market Cap
InterCure has a market cap or net worth of 169.16 million as of October 19, 2026. It is the 29,255th most valuable company in the world and the 341st biggest in Israel. Its market cap has decreased by 42.14% in one year.
Market Cap
169.16M
Enterprise Value
305.33M
Revenue
270.20M
Global Rank
Country Rank
#341 Israel
PE Ratio
n/a
ChartMarket Cap Chart
Since December 16, 2010, InterCure's market cap has increased from 6.36M to 169.16M, an increase of 2,558.72%. That is a compound annual growth rate of 22.99%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 19, 2026 | 169.16M | -4.40% |
| Dec 31, 2025 | 176.95M | -34.89% |
| Dec 31, 2024 | 271.76M | 28.77% |
| Dec 31, 2023 | 211.05M | -61.66% |
| Dec 29, 2022 | 550.52M | -40.95% |
| Dec 30, 2021 | 932.28M | 111.63% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Danel (Adir Yeoshua) | 2.72B |
| Amal Holdings A.D. | 2.21B |
| Rafa Laboratories | 1.79B |
| BrainsWay | 1.47B |
| Bonus BioGroup | 210.26M |
| Golden House | 157.96M |
| Rekah Pharmaceutical Industry | 120.42M |
| Epitomee Medical | 105.53M |